Levi levetiracetam tablets

Levi is a specific brand of levetiracetam, a medication primarily used to treat various types of seizures in patients with epilepsy. It is marketed as a prescription medicine intended for use under medical supervision. The brand is associated with the generic pharmaceutical market, where multiple manufacturers produce the active ingredient and finish the product in various global facilities.

The history of the medication dates back to the development of levetiracetam by UCB Pharma, though Levi represents a subsequent generic or branded generic version. In markets like Australia, it is commonly distributed by generic-focused healthcare firms or through specialized pharmaceutical supply chains. The manufacturing process often involves global sourcing of active pharmaceutical ingredients (API) with final tableting occurring in regions that meet strict regulatory standards for medical safety.